Back to Search Results
RTOG 0924
RTOG 0924, Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial.
The purpose of this study is to compare the effects of hormone therapy (androgen deprivation) and radiation therapy to the prostate gland and seminal vesicles with hormone therapy and radiation therapy to the whole pelvic body area on prostate cancer to find out which is better.
Principal Investigator:
Dr. Kiran Devisetty
Contact:
Study Coordinator
Phone (Main): 248-484-4962
IRB Number:
2012-00084
clinicaltrials.gov:
01368588
More Information: